(Q44461576)

English

Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

bioavailability

1 reference

based on heuristic

inferred from title

author name string

J L Italia

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

M M Yahya

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

D Singh

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

M N V Ravi Kumar

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

13 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pharmaceutical Research

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1324-1331

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9841-2

21 January 2018

Invasive aspergillosis in 2002: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9841-2

21 January 2018

Current role of therapy with amphotericin B

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9841-2

21 January 2018

Advances in the treatment of leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9841-2

21 January 2018

Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9841-2

21 January 2018

Lipid-based antifungal agents: current status

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amphotericin B and its delivery by liposomal and lipid formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formulation of amphotericin B as nanosuspension for oral administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amphotericin B: 30 years of clinical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles

1 reference

https://pubmed.ncbi.nlm.nih.gov/19214716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11095-009-9841-2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44461576&oldid=2024795808"